Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Suppression of Acute Experimental Colitis by a Highly Selective Inducible Nitric-Oxide Synthase Inhibitor,N-[3-(Aminomethyl)benzyl]acetamidine
Esko Kankuri, Kirsi Vaali, Richard G. Knowles, Mari Lähde, Riitta Korpela, Heikki Vapaatalo and Eeva Moilanen
Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 1128-1132;
Esko Kankuri
Kirsi Vaali
Richard G. Knowles
Mari Lähde
Riitta Korpela
Heikki Vapaatalo
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 298, Issue 3
1 Sep 2001
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Suppression of Acute Experimental Colitis by a Highly Selective Inducible Nitric-Oxide Synthase Inhibitor,N-[3-(Aminomethyl)benzyl]acetamidine
Esko Kankuri, Kirsi Vaali, Richard G. Knowles, Mari Lähde, Riitta Korpela, Heikki Vapaatalo and Eeva Moilanen
Journal of Pharmacology and Experimental Therapeutics September 1, 2001, 298 (3) 1128-1132;
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Suppression of Acute Experimental Colitis by a Highly Selective Inducible Nitric-Oxide Synthase Inhibitor,N-[3-(Aminomethyl)benzyl]acetamidine
Esko Kankuri, Kirsi Vaali, Richard G. Knowles, Mari Lähde, Riitta Korpela, Heikki Vapaatalo and Eeva Moilanen
Journal of Pharmacology and Experimental Therapeutics September 1, 2001, 298 (3) 1128-1132;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement